LG
NVO

Leuthold Group’s Novo Nordisk NVO Stock Holding History

Leuthold Group’s Portfolio NVO Stock Details NVO Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2020
Q4 		– Sell
-14,352
Closed -$498K – 187
2020
Q3 		$498K Sell
14,352
-398
-3% -$13.3K 0.07% 124
2020
Q2 		$483K Sell
14,750
-578
-4% -$18.4K 0.07% 114
2020
Q1 		$461K Sell
15,328
-1,424
-9% -$42.4K 0.08% 117
2019
Q4 		$485K Buy
+16,752
New +$464K 0.06% 125
2013
Q4 		– Sell
-112,650
Closed -$1.91M – 271
2013
Q3 		$1.91M Sell
112,650
-13,380
-11% -$225K 0.18% 151
2013
Q2 		$1.95M Buy
+126,030
New +$2.1M 0.18% 148

Other funds holding NVO

Renaissance Technologies
Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return
Fisher Asset Management
Fisher Asset Management Camas, Washington $295B AUM 31.6% 1-Year Est. Return
Bank of America
Bank of America Charlotte, North Carolina $1.37T AUM 24.88% 1-Year Est. Return
Loomis, Sayles & Company
Loomis, Sayles & Company Boston, Massachusetts $74.3B AUM 24.01% 1-Year Est. Return
F
Folketrygdfondet Oslo Norway, Norway $5.64B AUM 47.16% 1-Year Est. Return
Fayez Sarofim & Co
Fayez Sarofim & Co Houston, Texas $39.1B AUM 15.14% 1-Year Est. Return
Capital International Investors
Capital International Investors Los Angeles, California $427B AUM 29.17% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
State Farm Mutual Automobile Insurance
State Farm Mutual Automobile Insurance Bloomington, Illinois $127B AUM 32.55% 1-Year Est. Return
EHC
Everett Harris & Co Los Angeles, California $7.77B AUM 9.43% 1-Year Est. Return

Leuthold Group's NVO Position: Q4 2020 in Review

Leuthold Group sold out of Novo Nordisk (NVO) in Q4 2020, closing a stake of 14,352 shares — an estimated $498K sold.

Leuthold Group first reported a position in NVO in Q2 2013 and held it in 6 quarters. The position peaked at $1.95M in Q2 2013. 702 funds tracked by Wall St. Rank hold NVO as of Q4 2020.

  • Leuthold Group reported no remaining Novo Nordisk position as of Q4 2020 after selling out during the quarter.
  • Leuthold Group sold 14,352 Novo Nordisk shares in Q4 2020, an estimated $498K.
  • Leuthold Group first reported a position in Novo Nordisk in Q2 2013 and held it in 6 quarters.
  • Leuthold Group's Novo Nordisk position peaked at $1.95M in Q2 2013.
  • 702 funds tracked by Wall St. Rank held Novo Nordisk as of Q4 2020.

Based on Leuthold Group's 13F filing for Q4 2020, filed 16 Feb 2021.